More topics

Limited coverage drugs – indacaterol

Last updated on October 6, 2022

Generic name

indacaterol

Strength

75 mcg

Form

dry powder for oral inhalation

Special Authority criteria

Approval period

Diagnosis of chronic obstructive pulmonary disease (COPD) defined where a spirometry measure is:

  • A post-bronchodilator fixed ratio of forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) < 0.70

AND

Contraindication or intolerance to a long-acting muscarinic receptor antagonist (LAMA)

AND

Dosage does not exceed 75 mcg per day.

Indefinite

Practitioner exemptions

  • Respirologists are not required to submit a Special Authority request form for coverage.

Special notes

  • In remote areas, where spirometry access is limited, spirometry measurements are to be provided within 6 months.

Special Authority request form